Active substances
Diosmin + Hesperidin
- SFDA 3
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| Capillo | 450,50 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 31.30 | Generic · Prescription | RIYADH PHARMA | Valid |
| DAFLON 500MG TAB | 450,50 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 34.80 | NCE · Prescription | SERVIER | Valid |
| HENASEN 500MG F.C.TABLET | 450,50 mg,mg | Film-coated tablet · Oral use | 30 Blister | SAR 24.65 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
Indications — CHI Daman Drug Formulary
CHRONIC VENOUS INSUFFICIENCY; HEMORRHOIDS; VARICOSE VEINS
Components
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.